Dataset from A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel Group Study to Assess the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Had an Inadequate Response to Methylphenidate Therapy

This study will evaluate how long it takes for ADHD symptoms to improve in subjects who are
judged by the Investigator to have had an inadequate response to methylphenidate therapy. The
study will also test the safety of Lisdexamfetamine Dimesylate and how well it works.